APA

Shah N. N., Merchant M. S., Cole D. E., Jayaprakash N., Bernstein D., Delbrook C., Richards K., Widemann B. C. & Wayne A. S. (20160819). Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. : Pediatric blood & cancer.

Chicago

Shah Nirali N, Merchant Melinda S, Cole Diane E, Jayaprakash Nalini, Bernstein Donna, Delbrook Cindy, Richards Kelly, Widemann Brigitte C and Wayne Alan S. 20160819. Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. : Pediatric blood & cancer.

Harvard

Shah N. N., Merchant M. S., Cole D. E., Jayaprakash N., Bernstein D., Delbrook C., Richards K., Widemann B. C. and Wayne A. S. (20160819). Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. : Pediatric blood & cancer.

MLA

Shah Nirali N, Merchant Melinda S, Cole Diane E, Jayaprakash Nalini, Bernstein Donna, Delbrook Cindy, Richards Kelly, Widemann Brigitte C and Wayne Alan S. Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. : Pediatric blood & cancer. 20160819.